Cargando…

Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study

OBJECTIVE: To determine the value of [F-18]PBR06-PET for assessment of microglial activation in the cerebral gray matter in patients with MS. METHODS: Twelve patients with MS (7 relapsing-remitting and 5 secondary progressive [SP]) and 5 healthy controls (HCs) had standardized uptake value (SUV) PET...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhal, Tarun, O'Connor, Kelsey, Dubey, Shipra, Pan, Hong, Chu, Renxin, Hurwitz, Shelley, Cicero, Steven, Tauhid, Shahamat, Silbersweig, David, Stern, Emily, Kijewski, Marie, DiCarli, Marcelo, Weiner, Howard L., Bakshi, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624145/
https://www.ncbi.nlm.nih.gov/pubmed/31355321
http://dx.doi.org/10.1212/NXI.0000000000000587
_version_ 1783434210562801664
author Singhal, Tarun
O'Connor, Kelsey
Dubey, Shipra
Pan, Hong
Chu, Renxin
Hurwitz, Shelley
Cicero, Steven
Tauhid, Shahamat
Silbersweig, David
Stern, Emily
Kijewski, Marie
DiCarli, Marcelo
Weiner, Howard L.
Bakshi, Rohit
author_facet Singhal, Tarun
O'Connor, Kelsey
Dubey, Shipra
Pan, Hong
Chu, Renxin
Hurwitz, Shelley
Cicero, Steven
Tauhid, Shahamat
Silbersweig, David
Stern, Emily
Kijewski, Marie
DiCarli, Marcelo
Weiner, Howard L.
Bakshi, Rohit
author_sort Singhal, Tarun
collection PubMed
description OBJECTIVE: To determine the value of [F-18]PBR06-PET for assessment of microglial activation in the cerebral gray matter in patients with MS. METHODS: Twelve patients with MS (7 relapsing-remitting and 5 secondary progressive [SP]) and 5 healthy controls (HCs) had standardized uptake value (SUV) PET maps coregistered to 3T MRI and segmented into cortical and subcortical gray matter regions. SUV ratios (SUVRs) were global brain normalized. Voxel-by-voxel analysis was performed using statistical parametric mapping (SPM). Normalized brain parenchymal volumes (BPVs) were determined from MRI using SIENAX. RESULTS: Cortical SUVRs were higher in the hippocampus, amygdala, midcingulate, posterior cingulate, and rolandic operculum and lower in the medial-superior frontal gyrus and cuneus in the MS vs HC group (all p < 0.05). Subcortical gray matter SUVR was higher in SPMS vs RRMS (+10.8%, p = 0.002) and HC (+11.3%, p = 0.055) groups. In the MS group, subcortical gray matter SUVR correlated with the Expanded Disability Status Scale (EDSS) score (r = 0.75, p = 0.005) and timed 25-foot walk (T25FW) (r = 0.70, p = 0.01). Thalamic SUVRs increased with increasing EDSS scores (r = 0.83, p = 0.0008) and T25FW (r = 0.65, p = 0.02) and with decreasing BPV (r = −0.63, p = 0.03). Putaminal SUVRs increased with increasing EDSS scores (0.71, p = 0.009) and with decreasing BPV (r = −0.67, p = 0.01). On SPM analysis, peak correlations of thalamic voxels with BPV were seen in the pulvinar and with the EDSS score and T25FW in the dorsomedial thalamic nuclei. CONCLUSIONS: This study suggests that [F-18]PBR06-PET detects widespread abnormal microglial activation in the cerebral gray matter in MS. Increased translocator protein binding in subcortical gray matter regions is associated with brain atrophy and may link to progressive MS.
format Online
Article
Text
id pubmed-6624145
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-66241452019-07-26 Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study Singhal, Tarun O'Connor, Kelsey Dubey, Shipra Pan, Hong Chu, Renxin Hurwitz, Shelley Cicero, Steven Tauhid, Shahamat Silbersweig, David Stern, Emily Kijewski, Marie DiCarli, Marcelo Weiner, Howard L. Bakshi, Rohit Neurol Neuroimmunol Neuroinflamm Article OBJECTIVE: To determine the value of [F-18]PBR06-PET for assessment of microglial activation in the cerebral gray matter in patients with MS. METHODS: Twelve patients with MS (7 relapsing-remitting and 5 secondary progressive [SP]) and 5 healthy controls (HCs) had standardized uptake value (SUV) PET maps coregistered to 3T MRI and segmented into cortical and subcortical gray matter regions. SUV ratios (SUVRs) were global brain normalized. Voxel-by-voxel analysis was performed using statistical parametric mapping (SPM). Normalized brain parenchymal volumes (BPVs) were determined from MRI using SIENAX. RESULTS: Cortical SUVRs were higher in the hippocampus, amygdala, midcingulate, posterior cingulate, and rolandic operculum and lower in the medial-superior frontal gyrus and cuneus in the MS vs HC group (all p < 0.05). Subcortical gray matter SUVR was higher in SPMS vs RRMS (+10.8%, p = 0.002) and HC (+11.3%, p = 0.055) groups. In the MS group, subcortical gray matter SUVR correlated with the Expanded Disability Status Scale (EDSS) score (r = 0.75, p = 0.005) and timed 25-foot walk (T25FW) (r = 0.70, p = 0.01). Thalamic SUVRs increased with increasing EDSS scores (r = 0.83, p = 0.0008) and T25FW (r = 0.65, p = 0.02) and with decreasing BPV (r = −0.63, p = 0.03). Putaminal SUVRs increased with increasing EDSS scores (0.71, p = 0.009) and with decreasing BPV (r = −0.67, p = 0.01). On SPM analysis, peak correlations of thalamic voxels with BPV were seen in the pulvinar and with the EDSS score and T25FW in the dorsomedial thalamic nuclei. CONCLUSIONS: This study suggests that [F-18]PBR06-PET detects widespread abnormal microglial activation in the cerebral gray matter in MS. Increased translocator protein binding in subcortical gray matter regions is associated with brain atrophy and may link to progressive MS. Lippincott Williams & Wilkins 2019-07-01 /pmc/articles/PMC6624145/ /pubmed/31355321 http://dx.doi.org/10.1212/NXI.0000000000000587 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Article
Singhal, Tarun
O'Connor, Kelsey
Dubey, Shipra
Pan, Hong
Chu, Renxin
Hurwitz, Shelley
Cicero, Steven
Tauhid, Shahamat
Silbersweig, David
Stern, Emily
Kijewski, Marie
DiCarli, Marcelo
Weiner, Howard L.
Bakshi, Rohit
Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study
title Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study
title_full Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study
title_fullStr Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study
title_full_unstemmed Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study
title_short Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study
title_sort gray matter microglial activation in relapsing vs progressive ms: a [f-18]pbr06-pet study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624145/
https://www.ncbi.nlm.nih.gov/pubmed/31355321
http://dx.doi.org/10.1212/NXI.0000000000000587
work_keys_str_mv AT singhaltarun graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy
AT oconnorkelsey graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy
AT dubeyshipra graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy
AT panhong graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy
AT churenxin graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy
AT hurwitzshelley graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy
AT cicerosteven graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy
AT tauhidshahamat graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy
AT silbersweigdavid graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy
AT sternemily graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy
AT kijewskimarie graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy
AT dicarlimarcelo graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy
AT weinerhowardl graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy
AT bakshirohit graymattermicroglialactivationinrelapsingvsprogressivemsaf18pbr06petstudy